Clinical trial
Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With…
NCT00071968 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00071968 |
|---|---|
| Title | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse |
| Official title | An Open-Label Study Of Exploratory Pharmacogenomics And Pharmacologic Effects Of Neoadjuvant Oral CCI-779 In Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy Who Have A High Risk Of Relapse |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | temsirolimus, conventional surgery, neoadjuvant therapy |
| Enrollment | 15 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2006 |
| First posted | Nov 6, 2003 |
| Last update posted | Jan 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: